AJU IB Investment
Latest statistics and disclosures from AJU IB Investment's latest quarterly 13F-HR filing:
Tip: Access up to 7 years of quarterly data
Positions held by AJU IB Investment consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for AJU IB Investment
AJU IB Investment holds 7 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 44.4 | $26M | 1.4M | 18.77 |
|
|
| Rallybio Corp (RLYB) | 18.7 | $11M | 755k | 14.47 |
|
|
| Kymera Therapeutics (KYMR) | 17.0 | $9.9M | 457k | 21.77 |
|
|
| Seer Com Cl A (SEER) | 10.8 | $6.3M | 816k | 7.74 |
|
|
| Rapt Therapeutics (RAPT) | 4.1 | $2.4M | 100k | 24.06 |
|
|
| Xilio Therapeutics (XLO) | 3.3 | $1.9M | 668k | 2.91 |
|
|
| Sutro Biopharma (STRO) | 1.7 | $971k | 175k | 5.55 |
|
Past Filings by AJU IB Investment
SEC 13F filings are viewable for AJU IB Investment going back to 2021
- AJU IB Investment 2022 Q3 restated filed Nov. 14, 2022
- AJU IB Investment 2022 Q3 filed Nov. 7, 2022
- AJU IB Investment 2022 Q2 filed Aug. 9, 2022
- AJU IB Investment 2022 Q1 filed May 12, 2022
- AJU IB Investment 2021 Q4 filed Feb. 9, 2022
- AJU IB Investment 2021 Q3 filed Nov. 10, 2021
- AJU IB Investment 2021 Q2 filed Aug. 10, 2021
- AJU IB Investment 2020 Q4 filed May 12, 2021
- AJU IB Investment 2021 Q1 filed May 12, 2021